Literature DB >> 20396514

Correspondence (letter to the editor): Lucid scientific analysis.

Jens E Altwein.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20396514      PMCID: PMC2854969          DOI: 10.3238/arztebl.2010.0225a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

Review 1.  Good stress, bad stress--the delicate balance in the vasculature.

Authors:  Kirstin Wingler; Harald H H W Schmidt
Journal:  Dtsch Arztebl Int       Date:  2009-10-16       Impact factor: 5.594

Review 2.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anjana Bhardwaj; Rishi S Aggarwal; Navindra P Seeram; Shishir Shishodia; Yasunari Takada
Journal:  Anticancer Res       Date:  2004 Sep-Oct       Impact factor: 2.480

3.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Scott M Lippman; Eric A Klein; Phyllis J Goodman; M Scott Lucia; Ian M Thompson; Leslie G Ford; Howard L Parnes; Lori M Minasian; J Michael Gaziano; Jo Ann Hartline; J Kellogg Parsons; James D Bearden; E David Crawford; Gary E Goodman; Jaime Claudio; Eric Winquist; Elise D Cook; Daniel D Karp; Philip Walther; Michael M Lieber; Alan R Kristal; Amy K Darke; Kathryn B Arnold; Patricia A Ganz; Regina M Santella; Demetrius Albanes; Philip R Taylor; Jeffrey L Probstfield; T J Jagpal; John J Crowley; Frank L Meyskens; Laurence H Baker; Charles A Coltman
Journal:  JAMA       Date:  2008-12-09       Impact factor: 56.272

4.  Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Karla A Lawson; Margaret E Wright; Amy Subar; Traci Mouw; Albert Hollenbeck; Arthur Schatzkin; Michael F Leitzmann
Journal:  J Natl Cancer Inst       Date:  2007-05-16       Impact factor: 13.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.